Literature DB >> 18586966

Characterization of Salmonella enterica serovar Heidelberg from turkey-associated sources.

Pravin Kaldhone1, Rajesh Nayak, Aaron M Lynne, Donna E David, Patrick F McDermott, Catherine M Logue, Steven L Foley.   

Abstract

Salmonella enterica serovar Heidelberg strains are frequently associated with food-borne illness, with recent isolates showing higher rates of resistance to multiple antimicrobial agents. One hundred eighty S. enterica serovar Heidelberg isolates, collected from turkey-associated production and processing sources, were tested for antimicrobial susceptibility and compared by pulsed-field gel electrophoresis (PFGE) and plasmid profile analysis. The potential for the transfer of resistance between strains was studied by conjugation experiments. PFGE analysis using XbaI digestion identified eight clusters (based on 90% similarity), with the largest containing 71% of the isolates. Forty-two percent of the isolates were resistant to at least 1 of the 15 antimicrobial agents tested, and 4% of the isolates were resistant to 8 or more antimicrobial agents. Resistances to streptomycin (32%), tetracycline (30%), and kanamycin (24%) were most commonly detected. Interestingly, the XbaI PFGE profiles of selective multidrug-resistant strains (n = 22) of S. enterica serovar Heidelberg from turkey-associated sources were indistinguishable from the predominant profile (JF6X01.0022) detected in isolates associated with human infections. These isolates were further differentiated into seven distinct profiles following digestion with the BlnI enzyme, with the largest cluster comprising 15 isolates from veterinary diagnostic and turkey processing environments. Conjugation experiments indicated that resistance to multiple antimicrobial agents was transferable among strains with diverse PFGE profiles.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18586966      PMCID: PMC2519265          DOI: 10.1128/AEM.00409-08

Source DB:  PubMed          Journal:  Appl Environ Microbiol        ISSN: 0099-2240            Impact factor:   4.792


  23 in total

1.  Characterization of plasmids carrying CMY-2 from expanded-spectrum cephalosporin-resistant Salmonella strains isolated in the United States between 1996 and 1998.

Authors:  A Carattoli; F Tosini; W P Giles; M E Rupp; S H Hinrichs; F J Angulo; T J Barrett; P D Fey
Journal:  Antimicrob Agents Chemother       Date:  2002-05       Impact factor: 5.191

2.  International spread of bla(CMY-2)-mediated cephalosporin resistance in a multiresistant Salmonella enterica serovar Heidelberg isolate stemming from the importation of a boar by Denmark from Canada.

Authors:  Frank M Aarestrup; Henrik Hasman; Inger Olsen; Gitte Sørensen
Journal:  Antimicrob Agents Chemother       Date:  2004-05       Impact factor: 5.191

3.  Animal and human multidrug-resistant, cephalosporin-resistant salmonella isolates expressing a plasmid-mediated CMY-2 AmpC beta-lactamase.

Authors:  P L Winokur; A Brueggemann; D L DeSalvo; L Hoffmann; M D Apley; E K Uhlenhopp; M A Pfaller; G V Doern
Journal:  Antimicrob Agents Chemother       Date:  2000-10       Impact factor: 5.191

4.  Characterization of Salmonella enterica serotype newport isolated from humans and food animals.

Authors:  S Zhao; S Qaiyumi; S Friedman; R Singh; S L Foley; D G White; P F McDermott; T Donkar; C Bolin; S Munro; E J Baron; R D Walker
Journal:  J Clin Microbiol       Date:  2003-12       Impact factor: 5.948

5.  The incidence of antimicrobial-resistant Salmonella spp on freshly processed poultry from US Midwestern processing plants.

Authors:  C M Logue; J S Sherwood; P A Olah; L M Elijah; M R Dockter
Journal:  J Appl Microbiol       Date:  2003       Impact factor: 3.772

6.  Molecular epidemiological analysis and microbial source tracking of Salmonella enterica serovars in a preharvest turkey production environment.

Authors:  Rajesh Nayak; Tabitha Stewart-King
Journal:  Foodborne Pathog Dis       Date:  2008-04       Impact factor: 3.171

7.  Egg consumption is the principal risk factor for sporadic Salmonella serotype Heidelberg infections: a case-control study in FoodNet sites.

Authors:  Thomas W Hennessy; Lay Har Cheng; Heidi Kassenborg; Shama D Ahuja; Janet Mohle-Boetani; Ruthanne Marcus; Beletshachew Shiferaw; Frederick J Angulo
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

8.  Hospitalizations and deaths due to Salmonella infections, FoodNet, 1996-1999.

Authors:  Malinda Kennedy; Rodrigo Villar; Duc J Vugia; Therese Rabatsky-Ehr; Monica M Farley; Margaret Pass; Kirk Smith; Perry Smith; Paul R Cieslak; Beth Imhoff; Patricia M Griffin
Journal:  Clin Infect Dis       Date:  2004-04-15       Impact factor: 9.079

9.  Isolation and characterisation of Salmonella in a turkey production facility.

Authors:  R Nayak; P B Kenney; J Keswani; C Ritz
Journal:  Br Poult Sci       Date:  2003-05       Impact factor: 2.095

10.  Escherichia coli O157 cluster evaluation.

Authors:  Amita Gupta; Susan B Hunter; Sally A Bidol; Stephen Dietrich; Jennifer Kincaid; Ellen Salehi; Lisa Nicholson; Carol Ann Genese; Sarah Todd-Weinstein; Lisa Marengo; Akiko C Kimura; John T Brooks
Journal:  Emerg Infect Dis       Date:  2004-10       Impact factor: 6.883

View more
  15 in total

Review 1.  Population dynamics of Salmonella enterica serotypes in commercial egg and poultry production.

Authors:  Steven L Foley; Rajesh Nayak; Irene B Hanning; Timothy J Johnson; Jing Han; Steven C Ricke
Journal:  Appl Environ Microbiol       Date:  2011-05-13       Impact factor: 4.792

2.  Selection pressure required for long-term persistence of blaCMY-2-positive IncA/C plasmids.

Authors:  Murugan Subbiah; Eva M Top; Devendra H Shah; Douglas R Call
Journal:  Appl Environ Microbiol       Date:  2011-05-20       Impact factor: 4.792

3.  Comparison of Salmonella enterica serovar Heidelberg isolates from human patients with those from animal and food sources.

Authors:  Jing Han; Donna E David; Joanna Deck; Aaron M Lynne; Pravin Kaldhone; Rajesh Nayak; Rossina Stefanova; Steven L Foley
Journal:  J Clin Microbiol       Date:  2010-12-22       Impact factor: 5.948

4.  Evaluation of pulsed-field gel electrophoresis profiles for identification of Salmonella serotypes.

Authors:  Wen Zou; Wei-Jiun Lin; Steven L Foley; Chun-Houh Chen; Rajesh Nayak; James J Chen
Journal:  J Clin Microbiol       Date:  2010-07-14       Impact factor: 5.948

5.  Inc A/C plasmids are prevalent in multidrug-resistant Salmonella enterica isolates.

Authors:  Rebecca L Lindsey; Paula J Fedorka-Cray; Jonathan G Frye; Richard J Meinersmann
Journal:  Appl Environ Microbiol       Date:  2009-01-30       Impact factor: 4.792

Review 6.  Salmonella pathogenicity and host adaptation in chicken-associated serovars.

Authors:  Steven L Foley; Timothy J Johnson; Steven C Ricke; Rajesh Nayak; Jessica Danzeisen
Journal:  Microbiol Mol Biol Rev       Date:  2013-12       Impact factor: 11.056

Review 7.  Incompatibility Group I1 (IncI1) Plasmids: Their Genetics, Biology, and Public Health Relevance.

Authors:  Steven L Foley; Pravin R Kaldhone; Steven C Ricke; Jing Han
Journal:  Microbiol Mol Biol Rev       Date:  2021-04-28       Impact factor: 11.056

8.  Molecular and comparative analysis of Salmonella enterica Senftenberg from humans and animals using PFGE, MLST and NARMS.

Authors:  Ryan M Stepan; Julie S Sherwood; Shana R Petermann; Catherine M Logue
Journal:  BMC Microbiol       Date:  2011-06-27       Impact factor: 3.605

9.  DNA sequence analysis of plasmids from multidrug resistant Salmonella enterica serotype Heidelberg isolates.

Authors:  Jing Han; Aaron M Lynne; Donna E David; Hailin Tang; Joshua Xu; Rajesh Nayak; Pravin Kaldhone; Catherine M Logue; Steven L Foley
Journal:  PLoS One       Date:  2012-12-10       Impact factor: 3.240

10.  Impact of plasmids, including those encodingVirB4/D4 type IV secretion systems, on Salmonella enterica serovar Heidelberg virulence in macrophages and epithelial cells.

Authors:  Kuppan Gokulan; Sangeeta Khare; Anthony W Rooney; Jing Han; Aaron M Lynne; Steven L Foley
Journal:  PLoS One       Date:  2013-10-03       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.